Actithera Secures $75.5 Million in Oversubscribed Series A to Innovate Radioligand Therapy #Norway #Oslo #Series_A_Financing #Radioligand_Therapy #Actithera
0
0
0
0
Actithera Secures $75.5 Million in Oversubscribed Series A to Innovate Radioligand Therapy #Norway #Oslo #Series_A_Financing #Radioligand_Therapy #Actithera
Varana Capital's Strategic Investment in Arcuro Medical: A Milestone for 2025 Growth #United_States #Denver #Varana_Capital #Arcuro_Medical #Series_A_Financing